The healthcare industry in China is on the rise. Factors such as a growing middle class, a large aging population and greater instances of chronic disease, combined with the Chinese government’s commitments to healthcare investment and reform have attributed to this growth. Chinese government spending on healthcare increased by 27 percent in 2012. And, in 2011, China overtook Germany to become the 3rd largest pharmaceutical market with estimated value of $64 billion. By 2015, China is forecasted to be the 2nd largest market in Asia overtaking Japan in this space.